Impact of alirocumab/evolocumab on lipoprotein (a) concentrations in patients with familial hypercholesterolaemia: a systematic review and meta-analysis of randomized controlled trials
Endokrynologia Polska · 26.06.2023 · 74 (3) · 234-242
DOI: 10.5603/ep.a2023.0036 ↗Kurz gefasst
Metaanalyse in der Zeitschrift Endokrynologia Polska, online erschienen am 26.06.2023. Verfasst von Haibing Dai und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, Affiliated Hospital of Zunyi Medical University, Zunyi, China. 2832845671@qq.com. Hauptthemen laut MEDLINE: Hyperlipoproteinemia Type II, Anticholesteremic Agents. Die Arbeit wurde bisher 14-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Laboratory Medicine, Affiliated Hospital of Zunyi Medical University, Zunyi, China. 2832845671@qq.com.
- College of Laboratory Medicine, Zunyi Medical University, Zunyi, China. 2832845671@qq.com.
- Department of Laboratory Medicine, Affiliated Hospital of Zunyi Medical University, Zunyi, China.
- College of Laboratory Medicine, Zunyi Medical University, Zunyi, China.
- School of Population Medicine and Public Health, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Zitieren
APA
Dai, H., Zhu, Y., Chen, Z., Yan, R., Liu, J., He, Z., Zhang, L., Zhang, F., & Yan, S. (2023). Impact of alirocumab/evolocumab on lipoprotein (a) concentrations in patients with familial hypercholesterolaemia: a systematic review and meta-analysis of randomized controlled trials. Endokrynologia Polska, 74(3), 234-242. https://doi.org/10.5603/ep.a2023.0036
Vancouver
Dai H, Zhu Y, Chen Z, Yan R, Liu J, He Z, et al. Impact of alirocumab/evolocumab on lipoprotein (a) concentrations in patients with familial hypercholesterolaemia: a systematic review and meta-analysis of randomized controlled trials. Endokrynologia Polska. 2023;74(3):234-242. doi:10.5603/ep.a2023.0036
BibTeX
@article{Dai2023,
author = {Dai, Haibing and Zhu, Yonglin and Chen, Zuyi and Yan, Renqing and Liu, Jinsong and He, Ziyun and Zhang, Lin and Zhang, Feng and Yan, Shengkai},
title = {Impact of alirocumab/evolocumab on lipoprotein (a) concentrations in patients with familial hypercholesterolaemia: a systematic review and meta-analysis of randomized controlled trials},
journal = {Endokrynologia Polska},
year = {2023},
volume = {74},
number = {3},
pages = {234--242},
doi = {10.5603/ep.a2023.0036}
}
EUVIMED